Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
2.
Int J Antimicrob Agents ; 16(4): 429-34, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11118853

ABSTRACT

The widespread use of antiretroviral agents (ARVs) and the growing occurrence of HIV strains resistant to these drugs have given rise to serious concerns regarding the transmission of resistant viruses to newly infected persons. Plasma viral RNA from 80 individuals newly infected between 1997 and 1999 was genotyped by automated sequencing to analyze the profile of viruses resistant to nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTIs and NNRTIs) and to protease inhibitors (PIs). The prevalence of mutations that conferred primary resistance to PIs (L10I, D30Y, V82A, L90M) was 15% of the cohort. RT genotypic variants, associated with high-level resistance to ARVs, were observed in 21% of individuals, including NRTI, NNRTI and multidrug (MDR) resistance in 6, 5, and 10% of cases, respectively. The phenotypic susceptibility of viral isolates to ARVs was also assayed and showed transmission of high-level resistance to ZDV, 3TC, and PIs in those individuals with MDR. The transmission of drug-resistant HIV genotypic variants is a serious problem that merits further attention by public health officials, virologists, and clinicians.


Subject(s)
Anti-HIV Agents/pharmacology , HIV Infections/virology , HIV-1/drug effects , Anti-HIV Agents/therapeutic use , Drug Resistance, Microbial , Female , Gene Frequency , HIV Infections/drug therapy , HIV Protease/drug effects , HIV Protease/genetics , HIV Reverse Transcriptase/antagonists & inhibitors , HIV Reverse Transcriptase/genetics , HIV-1/enzymology , HIV-1/genetics , Humans , Male , Microbial Sensitivity Tests , Mutation , RNA, Viral/analysis , Reverse Transcriptase Inhibitors/pharmacology , Reverse Transcriptase Inhibitors/therapeutic use
3.
Infect Control Hosp Epidemiol ; 17(12): 811-3, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8985769

ABSTRACT

All methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from colonized or infected patients in a 625-bed public teaching hospital during an epidemic, and for 3 years thereafter, underwent susceptibility testing to mupirocin. Mupirocin resistance among MRSA increased markedly over this period (1990, 2.7%; 1991, 8.0%; 1992, 61.5%; 1993, 65%) in association with increased use of mupirocin ointment as an adjunct to infection control measures.


Subject(s)
Anti-Bacterial Agents , Cross Infection/drug therapy , Methicillin Resistance , Mupirocin , Staphylococcal Infections/drug therapy , Staphylococcus aureus , Administration, Intranasal , Cross Infection/microbiology , Drug Resistance, Microbial , Humans , Infection Control , Prevalence , Retrospective Studies , Staphylococcal Infections/microbiology
4.
J Clin Microbiol ; 34(1): 84-6, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8748279

ABSTRACT

We have previously found that approximately 3.5% of 428 clinical isolates of Mycobacterium tuberculosis yield uninterpretable results in the BACTEC pyrazinamide (PZA) susceptibility test system, because of inadequate growth. We tested the hypothesis that polyoxyethylene stearate (POES), the ingredient of the reconstituting fluid for the test, was the cause of this growth inhibition. A total of 15 isolates known for their previously uninterpretable results and 100 randomly chosen clinical isolates were tested in parallel both with and without POES. Repeat testing of the isolates with previously uninterpretable results yielded results in the presence of POES in only seven (47%). In the absence of POES, all gave interpretable results but one such result showed false resistance. For the other 100 clinical isolates, interpretable results were obtained with and without POES, but growth was enhanced in the absence of POES, especially in the PZA-susceptible strains. This was evidenced by a decreased time to attain a growth index of 200 in the control vial (4.9 days without POES versus 5.8 days with POES; P < 0.001) and a higher mean growth index ratio on the day of interpretation of the test (7.4% without POES versus 2.2% with POES; P < 0.001). However, the enhanced growth without POES led to 20 susceptible strains being misinterpreted as either resistant or borderline. We suggest that isolates of M. tuberculosis which yield uninterpretable results in the BACTEC PZA test system should be retested both with and without POES. If interpretable results indicating PZA resistance are obtained only in the absence of POES, the result should be confirmed by a pyrazinamidase assay or by the conventional proportion method. Routine omission of POES from the BACTEC test for all clinical strains is discouraged because of the unacceptably high false-resistance rates.


Subject(s)
Microbial Sensitivity Tests/methods , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/growth & development , Polyethylene Glycols/pharmacology , Antitubercular Agents/pharmacology , Cell Division/drug effects , Drug Resistance, Microbial , Humans , In Vitro Techniques , Indicators and Reagents , Microbial Sensitivity Tests/statistics & numerical data , Pyrazinamide/pharmacology , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/microbiology
5.
J Clin Microbiol ; 33(9): 2468-70, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7494049

ABSTRACT

The susceptibility of 428 clinical isolates of Mycobacterium tuberculosis to pyrazinamide was assessed by the Bactec method and the Wayne pyrazinamidase assay. The correlation between the two tests was 98.2 and 100% for susceptible and resistant strains, respectively. False resistance was seen in four (0.8%) strains with the Bactec test, and false-susceptible results occurred in two (0.5%) pyrazinamidase assays. The Bactec test is rapid and reliable, and the Bactec results correlate well with the pyrazinamidase test results, although some strains did not grow well in the test medium.


Subject(s)
Antitubercular Agents/pharmacology , Mycobacterium tuberculosis/drug effects , Pyrazinamide/pharmacology , Microbial Sensitivity Tests , Sensitivity and Specificity
6.
J Clin Microbiol ; 32(10): 2572-5, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7814501

ABSTRACT

The serogroup/serotypes (SGTs) and antimicrobial susceptibilities to 10 antimicrobial agents of 110 clinical strains of Streptococcus pneumoniae were determined. Strains intermediately resistant or highly resistant to penicillin G (80 of 110) belonged predominantly to SGTs 23 (45.0%), 19 (13.7%), 6 (10.0%), 9 (6.2%), and 14 (3.7%). The MICs of all cephalosporins, tetracycline, trimethoprim-sulfamethoxazole, and chloramphenicol increased along with the MICs of penicillin G. However, erythromycin resistance and clindamycin resistance were observed more frequently among the intermediately penicillin-resistant strains. Multiple resistance was observed for 32 strains, of which 25 were highly resistant to penicillin G and belong to SGT 23F. All strains were susceptible to vancomycin.


Subject(s)
Streptococcus pneumoniae/drug effects , Canada , Drug Resistance, Microbial , Humans , Microbial Sensitivity Tests , Penicillin Resistance
7.
Can J Infect Dis ; 5(1): 28-32, 1994 Jan.
Article in English | MEDLINE | ID: mdl-22346478

ABSTRACT

Two long term hospitalized patients developed disseminated infections caused by Mycobacterium chelonae, subspecies chelonae, over an eight-month period. In both cases, the disease was characterized by cutaneous and osseous involvement. The infections were indolent and marked by progressive bony destruction. These cases and a review of the literature are presented.

9.
Can J Anaesth ; 39(5 Pt 1): 509-11, 1992 May.
Article in English | MEDLINE | ID: mdl-1534525

ABSTRACT

Propofol, 2,6 diisopropylphenol, in an emulsion formulation (Diprivan), has been associated with postsurgical infections caused by Staphylococcus aureus, Moraxella osloensis and Candida albicans. These organisms were individually inoculated into each of the following media: (1) the emulsion preparation of propofol, (2) Intralipid 10%, (3) pure 2,6 diisopropylphenol, and (4) trypticase soy broth (TSB). The organisms were incubated and subcultured hourly for eight hours at room temperature. Propofol supported the growth of all three organisms, but for S. aureus and M. osloenis, the growth rate was slower in propofol than in TSB (P less than 0.05). There was no difference between the growth rate of any organism in propofol than in Intralipid 10%. The authors conclude that propofol, in the emulsion formulation, supports bacterial growth and, therefore, must be prepared for administration in an aseptic manner. Also, by administering propofol soon after preparation, the risk of introduction of a significant inoculum to the patient will be reduced.


Subject(s)
Candida albicans/growth & development , Caseins , Moraxella/growth & development , Propofol , Staphylococcus aureus/growth & development , Colony Count, Microbial , Culture Media , Fat Emulsions, Intravenous , Protein Hydrolysates , Regression Analysis , Temperature
10.
Can J Infect Control ; 7(1): 7-12, 1992.
Article in English | MEDLINE | ID: mdl-1525382

ABSTRACT

The emergence of acquired immune deficiency syndrome as a new and devastating communicable disease has led to concern among health care workers as to their risk of acquiring human immunodeficiency virus (HIV) in the workplace. Centres for Disease Control, and Health and Welfare Canada guidelines seek to prevent HIV transmission through modification of work practices. A study was performed in the authors' institution to quantitate health care worker compliance with such practice modifications as outlined in the researchers' institutional infection control procedures and to evaluate administrative and engineering controls related to this policy. An infection control program to educate health care workers and modify practices was being implemented prior to commencement of this study. Three areas were studied: emergency room, dental clinic and plastic surgery clinic. Adherence to established procedures was judged as compliant, noncompliant and interpretive compliant. Of 806 observations made on 24 health care workers in the three areas, 31.3% were compliant, 28% were noncompliant and 40.7% were interpretive complaint. The most serious non-compliance was noted in handling and disposal of needles. Use of gloves, eyewear, gowns or masks varied among the three sites. Administrative and engineering controls were lacking for eyewear, gowns, puncture-resistant containers and a written policy in some sites. The lack of compliance with institutional infection control procedures needs to be confirmed in other institutions. If there is generalized compliance failure, then a re-evaluation of the present strategies to reduce risk of HIV infection in health care workers is essential.


Subject(s)
Clinical Protocols/standards , Infection Control/methods , Personnel, Hospital/standards , Dental Clinics/standards , Emergency Service, Hospital/standards , Hospitals, Teaching , Humans , Program Evaluation , Quebec , Surgery, Plastic/standards
11.
J Clin Microbiol ; 29(12): 2758-62, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1757546

ABSTRACT

The National Committee for Clinical Laboratory Standards (NCCLS) recommends, as a quality control for the disk diffusion susceptibility test, the use of three strains from the American Type Culture Collection: Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa ATCC 27853, and Escherichia coli ATCC 25922. This study assesses the capacity of these strains to detect errors in the overall method. ATCC strains were tested by comparing testing by the standard NCCLS-recommended procedure (ST) with testing under the following conditions: incubation at 25 degrees C, Mueller-Hinton agar depths of 2 mm (AD2) and 8 mm (AD8), agar pHs of 6.5 and 8, inocula with McFarland standards of 0.25 (0.25M) and 4.0 McFarland (4.0M), direct inoculation without preincubation of inoculum (DI), and a 2-h delay between inoculation and disk application (2HR). The frequency of zone measurements outside the NCCLS-recommended control zone limits were as follows: ST, 0%; AD2, 18%; AD8, 9.6%; pH 6.5, 7.9%; pH 8, 5.3%; 0.25M, 3.5%; 4.0M, 24%; DI, 3.4%; 2HR, 1.8%; 25 degrees C (only E. coli and P. aeruginosa were evaluable), 28%. These results suggest that the quality control strains are only partially effective in detecting single extreme laboratory errors and that careful laboratory supervision is necessary even in the setting of properly monitored quality control strains.


Subject(s)
Clinical Laboratory Techniques/standards , Microbial Sensitivity Tests/standards , Escherichia coli/isolation & purification , Microbial Sensitivity Tests/methods , Pseudomonas aeruginosa/isolation & purification , Quality Control , Staphylococcus aureus/isolation & purification , United States
12.
Rev Infect Dis ; 13(6): 1093-104, 1991.
Article in English | MEDLINE | ID: mdl-1663650

ABSTRACT

Decision analysis was used in the evaluation of nine strategies for the prevention of neonatal infection with herpes simplex virus (HSV). These strategies involve physical examination at labor, weekly screening of pregnant women for shedding of HSV, use of serologic methods specific for HSV type 2, and performance of a rapid diagnostic test at labor. Rates of cesarean delivery and of neonatal infection with HSV were estimated for each strategy, and the estimates were compared with those for a strategy of no intervention. The effects of variations in the sensitivities and specificities of the diagnostic and serologic tests used were analyzed. Given the currently available data and technology, physical examination at labor is the optimal strategy if the primary goal is to minimize the ratio of excess cesarean sections to cases of neonatal HSV infection averted.


Subject(s)
Cesarean Section/statistics & numerical data , Decision Support Techniques , Herpes Simplex/prevention & control , Pregnancy Complications, Infectious/diagnosis , Antibodies, Viral/blood , Antigens, Viral/analysis , Evaluation Studies as Topic , Female , Genitalia, Female/microbiology , Herpes Simplex/congenital , Herpes Simplex/diagnosis , Humans , Infant, Newborn , Predictive Value of Tests , Pregnancy , Probability , Recurrence , Risk Factors , Simplexvirus/immunology , Simplexvirus/isolation & purification
14.
Arch Intern Med ; 151(6): 1197-201, 1991 Jun.
Article in English | MEDLINE | ID: mdl-2043021

ABSTRACT

Despite suspicion that inhalation of zirconium should be capable of causing human pulmonary disease, documentation of zirconium pneumoconiosis in humans has been lacking. We studied a likely case of zirconium compound-induced pulmonary fibrosis. The diagnosis was based on the following: (1) a history of gradual increase in symptoms and slowly progressing pulmonary fibrosis by chest roentgenogram compatible with a pneumoconiosis; (2) an appropriate history of exposure and a latency period of about 15 years before the onset of dyspnea and of roentgenographic changes; (3) analysis of open lung biopsy material revealing end-stage fibrosis and honeycombing, a moderate number of birefringent particles, and extremely high levels of a variety of zirconium compounds; and (4) no other potential cause of fibrosis. We conclude that zirconium should be considered a likely cause of pneumoconiosis and that appropriate precautions should be taken in the workplace.


Subject(s)
Occupational Diseases/chemically induced , Pulmonary Fibrosis/chemically induced , Zirconium/adverse effects , Humans , Lung/ultrastructure , Male , Microscopy, Electron, Scanning , Middle Aged , Pulmonary Fibrosis/diagnosis , Pulmonary Fibrosis/pathology , Respiratory Function Tests , Zirconium/analysis
15.
Can J Infect Dis ; 2(3): 121-8, 1991.
Article in English | MEDLINE | ID: mdl-22529721

ABSTRACT

The replication cycle of human immunodeficiency virus type 1 (HIV-1) and other retroviruses consists of four stages: attachment of the virus to specific receptors on the cell surface; uncoating of the viral nucleic acid and conversion to DNA; production of viral RNA and proteins; and assembly and liberation of progeny virus from the cell. Each of these steps represents a potential target for antiviral chemotherapy. Combinations of drugs which act against different steps in the viral replication cycle might be expected to have synergistic potential. Zidovudine (AZT) is the most widely used drug to date for impeding the replication of HIV-1. Although AZT therapy has been reasonably successful, it has not been free from toxicity. In addition, there have been several reports of isolation of AZT-resistant variants of HIV-1.

18.
J Otolaryngol ; 19(3): 195-6, 1990 Jun.
Article in English | MEDLINE | ID: mdl-2192076

ABSTRACT

A case of suppurative parotitis due to Streptococcus pneumoniae is reported in a patient with Sjögren's syndrome. The rarity of this condition is noted by a review of the literature.


Subject(s)
Parotitis/complications , Pneumococcal Infections/complications , Sjogren's Syndrome/complications , Humans , Male , Middle Aged , Parotitis/diagnosis , Parotitis/surgery , Pneumococcal Infections/diagnosis , Pneumococcal Infections/surgery , Streptococcus pneumoniae
19.
Can J Infect Dis ; 1(3): 73-6, 1990.
Article in English | MEDLINE | ID: mdl-22553444

ABSTRACT

Six clinical isolates of Enterococcus faecium highly resistant to penicillin are reported. These strains did not produce beta-lactamase and no plasmid DNA could be detected. It is postulated that the mechanism of resistance is one or more chromosomally mediated alterations of penicillin-binding proteins.

20.
Can J Infect Dis ; 1(3): 82-4, 1990.
Article in English | MEDLINE | ID: mdl-22553446

ABSTRACT

The first reported case of prostatic abscess caused by Streptococcus mutans isolated in pure culture is described. Urethral dilation for obstruction was unsuccessful, so suprapubic cystostomy was performed. Perineal aspiration under ultrasonic guidance resulted in 10 mL of pus containing pure Strep mutans. Diagnosis of prostatic abscess is difficult since the clinical manifestations are nonspecific.

SELECTION OF CITATIONS
SEARCH DETAIL
...